Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Buy
7,413
+916
+14% +$13.6K ﹤0.01% 1803
2026
Q1
$99.9K Sell
6,497
-1,102
-15% -$18.3K ﹤0.01% 1680
2025
Q4
$137K Buy
7,599
+334
+5% +$5.75K 0.01% 1339
2025
Q3
$117K Buy
7,265
+427
+6% +$6.25K 0.01% 1384
2025
Q2
$74.5K Sell
6,838
-14
-0.2% -$157 ﹤0.01% 1645
2025
Q1
$85.5K Buy
6,852
+141
+2% +$2.32K 0.01% 1395
2024
Q4
$133K Buy
6,711
+1,213
+22% +$13.4K 0.01% 920
2024
Q3
$44.9K Buy
5,498
+517
+10% +$3.51K ﹤0.01% 1564
2024
Q2
$33.9K Buy
4,981
+1,663
+50% +$11.4K ﹤0.01% 1478
2024
Q1
$16.6K Buy
3,318
+2,973
+862% +$6.33K ﹤0.01% 1771
2023
Q4
$1.21K Buy
+345
New +$823 ﹤0.01% 2740

Other funds holding MESO

GAMMA Investing's MESO Position: Q2 2026 in Review

GAMMA Investing increased its Mesoblast (MESO) stake by 14% in Q2 2026, buying an estimated $13.6K and bringing the position to 7,413 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

GAMMA Investing first reported a position in MESO in Q4 2023 and has held it in 11 quarters since. The position peaked at $137K in Q4 2025. 3 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • GAMMA Investing held 7,413 shares of Mesoblast worth $100K as of Q2 2026.
  • GAMMA Investing bought 916 Mesoblast shares in Q2 2026, an estimated $13.6K.
  • Mesoblast made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1803 holding.
  • GAMMA Investing first reported a position in Mesoblast in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Mesoblast position peaked at $137K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.